US FDA identifies four deaths in Newron schizophrenia trial
Newron Pharmaceuticals said the US FDA identified four deaths among patients treated with its experimental schizophrenia drug, in feedback following an earlier clinical hold.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.